Fulgent Genetics, Inc. FLGT Change in Accrued Liabilities
Change in Accrued Liabilities at other companies
Other financials
Where this comes from
Reported directly by Fulgent Genetics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities.
The official record: Fulgent Genetics, Inc.’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →
Ask your AI about Fulgent Genetics, Inc.'s change in accrued liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Fulgent Genetics, Inc.'s change in accrued liabilities?
- Fulgent Genetics, Inc. (FLGT) reported change in accrued liabilities of -$2.12M in Q1 2026.
- How has Fulgent Genetics, Inc.'s change in accrued liabilities changed year-over-year?
- Fulgent Genetics, Inc.'s change in accrued liabilities increased by 71.6% year-over-year, from -$7.49M to -$2.12M.
- What does change in accrued liabilities mean?
- Change in accrued expenses and other current liabilities, reflecting timing differences between expense recognition and cash payment.